Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control (Q42159558)

17 October 2017

Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control (English)

1 reference

17 October 2017

0 references

1 reference

3

Tracey E Schefter

1 reference

17 October 2017

Michelle A Stinauer

1

1 reference

17 October 2017

Brian D Kavanagh

2

1 reference

17 October 2017

Rene Gonzalez

4

1 reference

17 October 2017

Thomas Flaig

5

1 reference

17 October 2017

Karl Lewis

6

1 reference

17 October 2017

William Robinson

7

1 reference

17 October 2017

Mark Chidel

8

1 reference

17 October 2017

Michael Glode

9

1 reference

17 October 2017

David Raben

10

1 reference

17 October 2017

8 April 2011

1 reference

17 October 2017

1 reference

17 October 2017

6

1 reference

17 October 2017

34

1 reference

https://scigraph.springernature.com/pub.10.1186/1748-717x-6-34

17 October 2017

0 references

cites work

A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Stereotactic body radiotherapy in the management of painful bone metastases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Treatment of oligometastases after successful immunotherapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Stereotactic radiosurgery for patients with "radioresistant" brain metastases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

A review of human cell radiosensitivity in vitro

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Strategies for treating possible tumor extension: some theoretical considerations.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Radiation therapy in the treatment of metastatic renal cell carcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Fraction size in external beam radiation therapy in the treatment of melanoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

A challenge to traditional radiation oncology.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

The radiosensitivity of melanoma cells in culture

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094365

Tumor response to radiotherapy regulated by endothelial cell apoptosis

3 November 2018

1 reference

12 December 2020

Proceedings: Cancer of the kidney--radiation therapy and its indications in non-Wilms' tumors

1 reference

12 December 2020

Radiation therapy of malignant melanoma: experience with high individual treatment doses

1 reference

12 December 2020

The role of radiation therapy in the management of metastatic renal cell carcinoma

1 reference

12 December 2020

Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy

1 reference

12 December 2020

A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases

1 reference

12 December 2020

Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma

1 reference

12 December 2020

Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model

1 reference

12 December 2020

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases

1 reference

12 December 2020

Liver resection for metastases from renal cell carcinoma

1 reference

12 December 2020

Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma

1 reference

12 December 2020

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases

1 reference

12 December 2020

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-6-34

1 reference

Dimensions Publication ID

17 October 2017

0 references

1 reference

17 October 2017

1 reference